The outlook of companies tied to Viagra's history presents a complex investment scenario . While the initial boom generated substantial returns , generic alternatives have significantly impacted market share . Investing in related pharmaceutical businesses now requires a careful assessment of intellectual property safeguards, evolving healthcare sh